Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Australia’s December Trade Surplus Expands but Falls Short of Expectations 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings 
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Czech-based Mewery has introduced a prototype of microalgae-based cultivated meat, combining 75 percent pork cells and 25 percent microalgae cells.
The scientific team of Mewery, a cell-based food tech start-up, , cultivated this prototype in 10 weeks.
According to Mewery founder, Roman Lauš, they already have several variants that work for them without animal products and which they continue to work with.
The addition of microalgae improves the product's nutritional value by providing vitamins, antioxidants, minerals, fiber, and vital fatty acids.
Mewery hopes to have the finished product available for sale in two years. Once the necessary legislation is ready, consumers will have access to it.
